Zoetis Stock Quote Today

<div class='circular--portrait' style='background:#000000;color: #f2f2f2;font-size:3em;padding-top: 38px;;'>ZTS</div>
Zoetis is selling at 137.10 as of the 12th of July 2020; that is -0.42 percent decrease since the beginning of the trading day. The stock's lowest day price was 135.62. Zoetis has less than a 12 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 30 trading days. Equity ratings for Zoetis Inc are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 13th of April 2020 and ending today, the 12th of July 2020. Click here to learn more.
Analyze Filter   Report: 6th of August 2020

6 100 

   Odds of Distress

Zoetis Profile

The upcoming quarterly report is expected on the 6th of August 2020. Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on BATS Exchange. It employs 10600 people. more on Zoetis
Legal NameZoetis Inc
CEOKristin PeckView All
Thematic Classification
Currently Active Investing Idea
  Obamacare Repeal
View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Zoetis Inc. The Zoetis consensus assessment is calculated by taking the average estimates from all of the analysts covering Zoetis
Piotroski F Score
Academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Zoetis Inc financial position. Scores of 8 and 9 are usually clasified strong value stocks whereas scores of 2 or below are considered weak value stocks.
 4 - OrdinaryDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares537.3 M478.1 M
Moderately Up
Very volatile
Weighted Average Shares Diluted540.5 M481.8 M
Moderately Up
Net Cash Flow from Operations1.9 B1.8 B
Significantly Up
Slightly volatile
Total Assets9.3 B11.5 B
Significantly Down
Slightly volatile
Total Liabilities9.5 B8.8 B
Significantly Up
Slightly volatile
Current AssetsB4.7 B
Fairly Down
Slightly volatile
Current Liabilities1.5 B1.8 B
Significantly Down
Slightly volatile
Total Debt3.2 BB
Significantly Down
Slightly volatile
Return on Average Assets11.0313.4397
Significantly Down
Slightly volatile
Gross Margin62.9868.1789
Significantly Down
Slightly volatile
Asset Turnover0.680.5609
Fairly Up
Slightly volatile
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Zoetis available fundamental, technical, and predictive indicators. Current horizon is 30 days (very short) - details
Strong SellOvervalued
Financial Strength
Zoetis financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Zoetis success along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
BBB- ( Average Bond Rating ) Tolerable
  Operating Cash Flow
Zoetis Inc (ZTS) is traded on BATS Exchange in USA and employs 10,600 people. The company currently falls under 'Large-Cap' category with total capitalization of 65.39 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Zoetis's market, we take the total number of its shares issued and multiply it by Zoetis's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Zoetis Inc runs under Healthcare sector within Drug Manufacturers?Specialty & Generic industry. The entity has 474.94 M outstanding shares of which 4.36 M shares are at this time shorted by investors with about 2.09 days to cover shorted positions. has about 1.96 B in cash with 1.81 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.12.
Check Zoetis Probability Of Bankruptcy

Ownership Allocation (%)

Zoetis Stock Price Odds Analysis

Odds Down 137.1HorizonTargetOdds Up 137.1
79.99%30 days
Based on a normal probability distribution, the odds of Zoetis to move above the current price in 30 days from now is about 19.82 (This Zoetis Inc probability density function shows the probability of Zoetis Stock to fall within a particular range of prices over 30 days) .

Zoetis Stock Institutional Holders

InstituionSecurity TypeTotal SharesValue
Park National CorpCommon Shares134.7 K18.5 M
Pensionfund Dsm NetherlandsCommon Shares24.2 K3.3 M
View Zoetis Diagnostics

Zoetis Income Statement Over Time

Zoetis Inc Income Statement is one of the three primary financial statements used for reporting Zoetis's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Zoetis Inc revenue and expense. Zoetis Income Statement primarily focuses on the company's revenues and expenses during a particular period. Zoetis Selling General and Administrative Expense is relatively stable at the moment as compared to the past year. Zoetis reported last year Selling General and Administrative Expense of 1.57 Billion. As of 07/12/2020, Weighted Average Shares is likely to grow to about 537.3 M, while Cost of Revenue is likely to drop slightly above 1.9 B. View More Fundamentals

Zoetis Stock Against Markets

Did you try this?

Run Pattern Recognition Now


Pattern Recognition

Use different Pattern Recognition models to time the market across multiple global exchanges
All  Next Launch Module

Zoetis Upcoming and Recent Events

Zoetis Company Earnings Announcements Dates

Upcoming Quarterly Report6th of August 2020
Next Earnings Report5th of November 2020
Next Fiscal Quarter End30th of June 2020
Next Fiscal Year End11th of February 2021
Last Quarter Report31st of March 2020
Last Earning Announcement30th of June 2019

Zoetis Distributions to stockholders

A dividend is the distribution of a portion of Zoetis earnings, decided and managed by the Zoetiss board of directors and paid to a class of its shareholders. Note, announcements of dividend payouts are generally accompanied by a proportional increase or decrease in a company's stock price. Zoetis dividend payments follow a chronological order of events, and the associated dates are important to determine the shareholders who qualify for receiving the dividend payment.
16th of April 2020
16th of January 2020
21st of October 2019
18th of July 2019
17th of April 2019
17th of January 2019
19th of November 2018
19th of July 2018

Zoetis Corporate Directors

William Steere Independent Director
Linda Rhodes Independent Director
Frank DAmelio Independent Director
Check out Your Current Watchlist. Please also try Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page